Speakers

Dr. Jude Nwokike brings over 20 years of distinguished leadership in medical products development, quality assurance, regulatory systems strengthening, and pharmaceutical systems. As Vice President at USP he has led several global initiatives to ensure the quality and safety of medicines and spearheaded efforts to enhance the adoption of manufacturing standards and regulatory frameworks across nearly 60 countries, overcoming bottlenecks to accelerate access to life-saving medicines and vaccines.

Before joining USP, Dr. Nwokike served as the U.S. FDA liaison to the Center for Drug Evaluation and Research, supporting the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) antiretroviral drugs program. In this role, he coordinated with pharmaceutical companies to streamline their participation in the FDA expedited review process for antiretroviral drugs (ARVs) and collaborated with the World Health Organization (WHO) to share information on FDA’s tentatively approved and approved ARVs, facilitating reliance and timely access of ARVs for global health programs. Earlier, Dr. Nwokike held several global technical leadership roles where he advanced product quality assurance, regulatory harmonization, and pharmaceutical supply systems strengthening. His nearly decade-long tenure in the pharmaceutical industry honed his expertise in late-phase product development, manufacturing standards, sales and marketing, and delivering high-quality pharmaceuticals to diverse markets.

A globally recognized expert, Dr. Nwokike excels in translating complex regulatory and medical products challenges into actionable solutions. He has led multiple large programs focusing on product development and quality assurance, enhancing manufacturing capacity and regulatory systems worldwide. His strategic oversight has ensured compliance with international standards, while his innovative approaches have optimized production processes and improved product quality around the world.

Dr. Nwokike chairs the WHO’s Global Steering Group for the Coalition of Interested Parties (CIP) Network, guiding regulatory systems strengthening efforts. His contributions to industrial pharmacy earned him the prestigious 2020 IPS Medal Award from the International Pharmaceutical Federation (FIP). A mentor to thousands of technical experts, he has built high-performing teams that excel in product development, manufacturing excellence, and quality assurance, leaving a lasting impact on the pharmaceutical sector and global health.